A detailed history of Janus Henderson Group PLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 5,433,557 shares of EW stock, worth $360 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
5,433,557
Previous 5,276,857 2.97%
Holding current value
$360 Million
Previous $504 Million 0.47%
% of portfolio
0.28%
Previous 0.28%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $13.2 Million - $14.8 Million
156,700 Added 2.97%
5,433,557 $502 Million
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $21.3 Million - $28.1 Million
-293,761 Reduced 5.27%
5,276,857 $504 Million
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $43 Million - $54.2 Million
696,509 Added 14.29%
5,570,618 $425 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $52.4 Million - $70.7 Million
756,762 Added 18.38%
4,874,109 $338 Million
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $6.83 Million - $7.91 Million
-83,848 Reduced 2.0%
4,117,347 $388 Million
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $27.8 Million - $31.7 Million
374,517 Added 9.79%
4,201,195 $348 Million
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $244 Million - $312 Million
-3,572,054 Reduced 48.28%
3,826,678 $286 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $44.8 Million - $58.3 Million
-543,403 Reduced 6.84%
7,398,732 $611 Million
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $188 Million - $278 Million
-2,168,122 Reduced 21.44%
7,942,135 $755 Million
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $38.6 Million - $48.6 Million
-379,059 Reduced 3.61%
10,110,257 $1.19 Billion
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $75.7 Million - $93 Million
-711,326 Reduced 6.35%
10,489,316 $1.36 Billion
Q3 2021

Nov 16, 2021

SELL
$102.91 - $122.75 $91.2 Million - $109 Million
-886,403 Reduced 7.33%
11,200,642 $1.27 Billion
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $75.7 Million - $94.6 Million
-903,071 Reduced 6.95%
12,087,045 $1.25 Billion
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $256 Million - $295 Million
3,249,102 Added 33.35%
12,990,116 $1.09 Billion
Q4 2020

Feb 16, 2021

BUY
$71.69 - $91.23 $170 Million - $216 Million
2,365,014 Added 32.06%
9,741,014 $889 Million
Q3 2020

Nov 16, 2020

BUY
$67.19 - $87.44 $36.3 Million - $47.2 Million
539,807 Added 7.9%
7,376,000 $589 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $261 Million - $350 Million
4,542,982 Added 198.11%
6,836,193 $472 Million
Q1 2020

May 14, 2020

SELL
$52.41 - $81.0 $7.04 Million - $10.9 Million
-134,402 Reduced 5.54%
2,293,211 $433 Million
Q4 2019

Feb 18, 2020

BUY
$71.7 - $82.09 $12.8 Million - $14.7 Million
179,046 Added 7.96%
2,427,613 $566 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $12.6 Million - $15.5 Million
-205,336 Reduced 8.37%
2,248,567 $165 Million
Q2 2019

Jul 31, 2019

SELL
$55.74 - $64.41 $10.4 Million - $12.1 Million
-187,134 Reduced 7.09%
2,453,903 $453 Million
Q1 2019

Apr 30, 2019

SELL
$47.89 - $64.05 $18.5 Million - $24.8 Million
-386,958 Reduced 12.78%
2,641,037 $505 Million
Q4 2018

Feb 06, 2019

BUY
$46.41 - $56.94 $24.3 Million - $29.8 Million
522,867 Added 20.87%
3,027,995 $464 Million
Q3 2018

Nov 09, 2018

BUY
$45.7 - $58.03 $61.7 Million - $78.4 Million
1,350,879 Added 117.04%
2,505,128 $436 Million
Q2 2018

Aug 10, 2018

BUY
$42.45 - $51.3 $1.67 Million - $2.02 Million
39,390 Added 3.53%
1,154,249 $168 Million
Q1 2018

May 14, 2018

SELL
$37.19 - $47.45 $5,615 - $7,164
-151 Reduced 0.01%
1,114,859 $156 Million
Q4 2017

Feb 09, 2018

BUY
$33.79 - $39.39 $16.7 Million - $19.5 Million
495,307 Added 79.93%
1,115,010 $126 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $20.7 Million - $22.1 Million
569,525 Added 1135.01%
619,703 $0
Q2 2017

Aug 17, 2017

BUY
N/A
50,178
50,178 $5.93 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.